Izrael - hebrejščina - Ministry of Health

novartis israel ltd - topotecan as hydrochloride - אבקה להכנת תמיסה לאינפוזיה - topotecan as hydrochloride 4 mg/vial - topotecan - topotecan - treatment of metastatic carcinoma of the ovary after failure of initial or subsequent therapy. treatment of small cell lung cancer sensitive disease after failure of first line chemotherapy. topotecan in combination with cisplatin is indicated for the treatment of stage iv-b recurrent or persistent carcinoma of the cervix which is not amenable to curative treatment with surgery and/or radiation therapy.

Izrael - hebrejščina - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Izrael - hebrejščina - Ministry of Health

novartis israel ltd - vinorelbine as tartrate - תרכיז להכנת תמיסה לאינפוזיה - vinorelbine as tartrate 10 mg/ml - for the treatment of non small cell lung cancer. for the treatment of advanced breast cancer. hormone- refractory prostate cancer, especially in combination with low dose oral corticoid therapy or estramustin.

Izrael - hebrejščina - Ministry of Health

perrigo israel agencies ltd - milnacipran hydrochloride - קפסולות - milnacipran hydrochloride 25 mg - milnacipran - milnacipran - treatment of major (i.e. all characteristics) depressive episodes in adults over 18 years old.

Izrael - hebrejščina - Ministry of Health

glaxo smith kline (israel) ltd - fluticasone propionate - תרחיף - fluticasone propionate 0.05 g / 100 g - fluticasone - fluticasone - prophylaxis and treatment of seasonal allergic rhinitis including hayfever, and perennial rhinitis. perenial rhinitis in children of the age of 4 years.

Izrael - hebrejščina - Ministry of Health

trima israel pharmaceutical products maabarot ltd - fluticasone propionate - תרחיף - fluticasone propionate 0.05 %w/w - fluticasone - fluticasone - prophylaxis and treatment of seasonal allergic rhinitis including hay fever and perenial rhinitis.

Izrael - hebrejščina - Ministry of Health

pharma shalom - triamcinolone acetonide - תרחיף - triamcinolone acetonide 0.055 %w/w - triamcinolone - triamcinolone - for the treatment of nasal symptoms of seasonal and perennial allergic rhinitis in adults and children 2 years of age and older.

Izrael - hebrejščina - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - טבליות לעיסות - montelukast as sodium 5 mg - montelukast - montelukast - singulair 5 mg is indicated in adult and pediatric patients 6 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singular is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and padiatric patients 2 years of age and older.

Izrael - hebrejščina - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - טבליה - montelukast as sodium 10 mg - montelukast - montelukast - singulair 10 mg is indicated in adult and adolescents 15 years of age and older for the prophylaxis and chronic treatment of asthma including prevention of daytime and nighttime symptoms the treatment of aspirin-sensitive asthmatic patients and the prevention of exercise-induced bronchoconstriction. singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled corticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singular is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and padiatric patients 2 years of age and older.

Izrael - hebrejščina - Ministry of Health

organon pharma israel ltd., israel - montelukast as sodium - טבליות לעיסות - montelukast as sodium 4 mg - montelukast - montelukast - singulair is indicated in pediatric patients 2 years of age and older for the prophylaxis and chronic treatment of asthma, including prevention of daytime and nighttime symptoms, the treatment of aspirin-sensitive asthmatic patients, and the prevention of exercise-induced bronchoconstriction.singulair is effective alone or in combination with other agents used in the maintenance treatment of chronic asthma. singulair and inhaled carticosteroids may be used concomitantly with additive effects to control asthma or to reduce the inhaled corticosteroid dose while maintaining clinical stability. singular is indicated for the relief of symptoms of seasonal allergic rhinitis in adults and padiatric patients 2 years of age and older.